Patents by Inventor Mark Barton Frank

Mark Barton Frank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140200826
    Abstract: Quantitative datasets are created and used in the identification, monitoring and treatment of disease states and characterization of biological conditions.
    Type: Application
    Filed: March 27, 2014
    Publication date: July 17, 2014
    Applicant: Oklahoma Medical Research Foundation
    Inventors: Michael Centola, Philip J. Alex, Nicholas Knowlton, Mark Barton Frank
  • Publication number: 20100261613
    Abstract: Quantitative expression datasets are created and used in the identification, monitoring and treatment of disease states and characterization of biological conditions. Quantitative datasets are derived from subject samples and enable evaluation of a biological condition. Such quantitative datasets may be used to provide an output score indicative of the biological state of a subject through analysis against a profile dataset.
    Type: Application
    Filed: July 28, 2008
    Publication date: October 14, 2010
    Inventors: Michael Centola, Philip Alex, Nicholas Knowlton, Mark Barton Frank
  • Patent number: 6111088
    Abstract: Complementary DNA encoding a 52 kDa form of a protein present in the human Ro/SSA ribonucleoprotein complex has been cloned. A lambda gt11 cDNA library made from human thymocyte mRNA was screened with serum from a SLE patient and two immunoreactive clones were isolated. These clones reacted with other patient sera which had anti-52 kDa Ro/SSA antibodies and with affinity purified anti-52 kDa Ro/SSA antibodies. Moreover, affinity purified antibodies eluted from fusion proteins of the isolated clones reacted only with the 52 kDa protein of lymphocytes in the Western blot. Ro/SSA RNAs were also precipitated with these affinity purified antibodies, further confirming that the clones encode a 52 kDa Ro/SSA antigen. The sequence differs from the previously reported 60 kDa Ro/SSA gene.
    Type: Grant
    Filed: September 16, 1992
    Date of Patent: August 29, 2000
    Assignee: Oklahoma Medical Research Foundation
    Inventors: Mark Barton Frank, Kazuko Itoh